Not available
Quote | Atara Biotherapeutics Inc. (NASDAQ:ATRA)
Last: | $7.52 |
---|---|
Change Percent: | 0.24% |
Open: | $8.34 |
Close: | $7.52 |
High: | $8.34 |
Low: | $7.3101 |
Volume: | 93,158 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Atara Biotherapeutics Inc. (NASDAQ:ATRA)
2024-06-27 22:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Ebvallo is the First and Only Approved Therapy in Europe for Adults and Children with EBV+ PTLD Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies ...
Message Board Posts | Atara Biotherapeutics Inc. (NASDAQ:ATRA)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $ATRA News Article - Atara Biotherapeutics to Announce First Quarter 2023 Financial Res | whytestocks | investorshangout | 05/01/2023 8:20:47 PM |
whytestocks: $ATRA News Article - Atara Biotherapeutics to Announce Fourth Quarter and Full Year 202 | whytestocks | investorshangout | 02/06/2023 3:35:45 PM |
whytestocks: $ATRA News Article - CHMP Recommends Approval of Atara Biotherapeutics' Ebvallo(TM) (ta | whytestocks | investorshangout | 10/14/2022 12:05:54 PM |
znewcar1: ATRA 25% v6,2M c5.84 f94,4M H5.87 ML2.83 | znewcar1 | investorshangout | 08/12/2022 8:46:00 PM |
znewcar1: ATRA 29% v14,5M c4.69 f93,4M H4.92 ML2.83 gap down | znewcar1 | investorshangout | 08/09/2022 8:10:31 PM |
News, Short Squeeze, Breakout and More Instantly...
Atara Biotherapeutics Inc. Company Name:
ATRA Stock Symbol:
NASDAQ Market:
Atara Biotherapeutics Inc. Website:
2024-06-27 22:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Ebvallo is the First and Only Approved Therapy in Europe for Adults and Children with EBV+ PTLD Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies ...
2024-06-20 09:02:05 ET Atara Biotherapeutics Inc (ATRA) announced stock split at a ratio of 1-for-25 on 2024-06-20 ... Full story available on KlickAnalytics.com